Aleksandar Nagorni

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Bruce E. Sands, Peter M. Irving, Timothy Hoops et al. · The Lancet · 2022 · 277 citations

Immunology, Clinical Trials, Gastroenterology +7

Irritable bowel syndrome, anxiety, depression and personality characteristics.

S. Tošić-Golubović, Srbobran Miljković, Aleksandar Nagorni et al. · PubMed · 2010 · 67 citations

The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding

Daniela Benedeto-Stojanov, Aleksandar Nagorni, Goran Bjelaković et al. · Vojnosanitetski pregled · 2009 · 45 citations · Full text

Dietary factors and gastric cancer risk: hospital-based case control study.

Konstansa Lazarević, Aleksandar Nagorni, Nataša Rančić et al. · PubMed · 2010 · 36 citations